Tag: Cancer recurrence

The return of a disease after a period of remission is a significant medical event. Knowing what is a recurrence of a disease, understanding its triggers, and identifying the risk factors is vital for patients and their families seeking to manage their long-term health and well-being.

For many cancer patients, a critical step after diagnosis is understanding their prognosis and treatment options. A personalized genomic test provides insight into a tumor's specific biology. The **recurrence risk score** is a powerful tool derived from this analysis, offering a personalized estimate of the likelihood of cancer returning after initial treatment.

According to the National Cancer Institute, a recurrence is the return of a disease after a period of remission. A clear understanding of what is a recurrence in medical terms is vital for patients and caregivers navigating a health journey that may include chronic conditions or the aftermath of cancer treatment.

Recurrence, or relapse, is a medical term for the return of a disease after a period of remission. While the initial diagnosis is often the most shocking, the possibility of the disease returning can be equally daunting. This raises the critical question, **can recurrence be cured?**

According to the American Cancer Society, a complete remission does not mean the cancer has been cured, only that it is not visible on tests. This highlights the critical reality of disease recurrence—the return of a disease after a period of remission.

According to the National Cancer Institute, a complete remission signifies that all signs and symptoms of cancer have disappeared due to treatment. However, this does not mean the cancer has been cured, a distinction that is often a source of confusion and anxiety for many survivors and their families. This article provides a comprehensive overview to answer the question, **Does complete remission mean cured?**

According to the National Cancer Institute, the 5-year relative survival rate for all cancers combined reached 72.5% for patients diagnosed between 2017 and 2019, signifying a major improvement in outcomes. However, this statistic doesn't define an individual's prognosis, and the question remains: `What happens after a 5 year survival rate?`